How a Common Chemo Drug Eats Away at Muscle, and a Possible Way to Block It
Graded Preliminary — knockout and agonist study in mice over a four-day cisplatin course, with no human data and one muscle measure showing no group difference.
Animal study. Findings may not carry over to people, which is why the grade is capped at Preliminary.
Cisplatin is a widely used cancer drug, but it often wastes away muscle. In mice, scientists found that an immune signaling pathway called cGAS-STING drives much of this muscle loss. Switching off this pathway in muscle helped protect it from the drug's damage. This points to a possible target for keeping muscle intact during chemo.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchNMN Calmed Eye Inflammation and Slowed Blood Vessel Damage in Mice
Wet macular degeneration happens when abnormal blood vessels grow under the retina and scar tissue forms.
How Exercise Quiets a Muscle-Wasting Inflammation Signal in Older Women
Scientists found a specific inflammation signal called CXCL2 that climbs as muscle loss gets worse with age.
NMN Protected Rat Testes From Chemotherapy Damage in Early Study
The chemo drug doxorubicin badly damages the testes, a real worry for male cancer patients.